Washington, February 23
An international team of researchers during a recent study found that adults who suffer from Down syndrome have a higher risk of death due to COVID-19, in comparison to the general population. The study implicated that vaccinating people with genetic disorders should be prioritised.
Investigators found that adults with Down syndrome were roughly three times more likely to die from COVID-19 than the general population. This increased risk was especially apparent in the fifth decade of life: A 40-year-old with Down syndrome had a similar risk of dying from COVID-19 as someone 30 years older in the general population. The study was published this week in The Lancet’s ‘EClinical Medicine’.
“Our results, which are based on more than 1,000 COVID-19 unique patients with Down syndrome, show that individuals with Down syndrome often have more severe symptoms at hospitalisation and experience high rates of lung complications associated with increased mortality,” said Anke Huels, an assistant professor of epidemiology at Emory University’s Rollins School of Public Health, and the study’s first author.
Huels added, “These results have implications for preventive and clinical management of COVID-19 patients with Down syndrome and emphasise the need to prioritise individuals with Down syndrome for vaccination…